🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

QMSMEDI.NS,0P0001PRY4,16000 QMSMEDI NSEPHARMA

Healthcare · Medical Instruments & Supplies · India
https://qmsmas.com
Company Profile ↓
₹109.40
+24.97% 1Y
Mkt Cap₹183.71 Cr
P/E48.22
P/B3.43
Div. Yield0.52%
52W High₹109.40
52W Low₹72.00
Book Value₹29.67
EPS (TTM)₹2.11

Company Overview

QMS Medical Allied Services Limited distributes medical and healthcare devices in India. The company also manufactures and sells glucometers, pulse oximeters, IR thermometers, BP monitors, anatomy sets, neurology kits, orthopedic aids, and weighing scales, etc.; and operates QMSMEDS, an e-commerce platform that sells healthcare devices of various brands. In addition, the company provides diagnostic and patient management services, including ambulatory blood pressure tracking, continuous blood glucose and blood pressure/glucose monitoring, tonometry, and HbA1C services. Further, it offers Educamedics, which provides customized scientific content in the form of conferences, online courses, webinars, recorded lectures, and others. Additionally, the company offers chemical and chemical products, pharmaceuticals, and medicinal chemical and botanical products. QMS Medical Allied Services Limited was founded in 1994 and is based in Mumbai, India.

Recent Developments

  • Mar 2026 Revenue of ₹81.68 Cr (-7.7% YoY); net profit ₹4.08 Cr.
  • Trailing 12 Months Year-on-year growth — revenue -0.4%, earnings -73.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR -7.7%, profit CAGR -13.8%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-7.75%
1 Year:-0.40%

Compounded Profit Growth

5 Years:-13.81%
1 Year:-73.80%

Stock Price Performance

1 Year:+24.97%
6 Months:+16.88%
3 Months:+36.24%
1 Month:+31.81%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 100% of range
₹72.00 ₹109.40
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)79.98 · Overbought
Price Performance
1M+31.81%
3M+36.24%
6M+16.88%
1Y+24.97%
Valuation vs Sector

P/E of 48.22 is above the sector median of 36.33 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Revenue declined at -7.7% CAGR over 5 years.
  • Earnings shrank at -13.8% CAGR over 5 years.
  • In a downtrend (50-DMA below 200-DMA).
  • RSI at 80 suggests overbought conditions.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
48.22
Industry PE
36.33
Forward P/E est.
96.45
PEG Ratio
-
Book Value
₹29.67
Price to Book
3.43
P/S
1.06
EV/EBITDA
16.16
Dividend Yield
0.52%

Growth (CAGR)

Revenue 5Y
-7.75%
Profit 5Y
-13.81%
Revenue (YoY)
-0.40%
Earnings (YoY)
-73.80%

Profitability & Returns

ROCE
8.96%
ROE
10.78%
ROA
6.81%
Profit Margin
5.86%
Op Margin
10.46%
Gross Margin
46.42%
EPS (Latest Qtr)
₹0.89
EPS (TTM)
₹2.11

Balance Sheet & Liquidity

Debt/Equity
0.65
Quick Ratio
0.81
Current Ratio
1.56
Debt
₹74.48 Cr
Total Assets
₹212.85 Cr
Current Assets
₹142.01 Cr
Working Capital
₹50.74 Cr

Ownership

Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹418.24 Cr
Total Revenue (TTM)
₹172.88 Cr
EBITDA
₹25.88 Cr
Free Cash Flow
₹-10.38 Cr
Operating Cash Flow
₹19.44 Cr
Shares Outstanding
₹1.81 Cr
Gross Margin
46.42%
Payout Ratio
23.70%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 QMSMEDI QMSMEDI.NS,0P0001PRY4,16000 NSEPHARMA 109.40 48.22 ₹183.71 Cr 0.52% 8.96% 10.78% -7.75% -13.81%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,820.40 38.08 ₹4.37 L Cr 0.89% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,663.50 68.87 ₹1.77 L Cr 0.45% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,442.80 78.68 ₹1.50 L Cr 0.83% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,427.50 62.41 ₹1.21 L Cr 0.24% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,350.80 20.71 ₹1.09 L Cr 0.94% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,061.40 21.19 ₹1.07 L Cr 0.09% 19.24% 18.59% 16.55% 36.99%
8 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,269.00 24.68 ₹1.06 L Cr 0.63% 14.22% 11.36% 10.96% -1.67%
9 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,272.00 19.51 ₹1.04 L Cr 0.52% 28.42% 23.76% 19.10% 131.46%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --44.58 Cr46.49 Cr44.70 Cr37.26 Cr44.42 Cr
Cost of Revenue --21.93 Cr25.93 Cr25.57 Cr18.86 Cr22.26 Cr
Gross Profit --22.65 Cr20.56 Cr19.13 Cr18.39 Cr22.16 Cr
Operating Expenses --17.63 Cr14.98 Cr13.15 Cr12.67 Cr17.51 Cr
Operating Income --5.02 Cr5.58 Cr5.98 Cr5.73 Cr4.65 Cr
EBITDA --7.47 Cr6.76 Cr7.14 Cr7.05 Cr5.99 Cr
Interest Expense --1.41 Cr1.42 Cr1.36 Cr1.75 Cr2.02 Cr
Pretax Income --4.69 Cr4.48 Cr4.84 Cr4.27 Cr2.84 Cr
Tax Provision --1.09 Cr1.33 Cr1.27 Cr1.10 Cr82.47 L
Net Income --3.34 Cr2.93 Cr3.12 Cr3.17 Cr1.72 Cr
Diluted EPS --1.841.621.711.240.89

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -104.04 Cr122.13 Cr88.45 Cr81.68 Cr
Cost of Revenue -77.88 Cr79.92 Cr45.17 Cr41.13 Cr
Gross Profit -26.16 Cr42.20 Cr43.28 Cr40.55 Cr
Operating Expenses -15.84 Cr27.30 Cr32.18 Cr30.18 Cr
Operating Income -10.32 Cr14.91 Cr11.10 Cr10.37 Cr
EBITDA -11.78 Cr18.80 Cr16.21 Cr14.83 Cr
Interest Expense -2.00 Cr3.13 Cr2.73 Cr3.77 Cr
Pretax Income -8.71 Cr12.24 Cr9.66 Cr7.12 Cr
Tax Provision -2.32 Cr3.23 Cr2.59 Cr1.93 Cr
Net Income -6.38 Cr9.00 Cr6.26 Cr4.08 Cr
Diluted EPS 5.923.864.983.44-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -117.74 Cr135.32 Cr189.79 Cr212.85 Cr
Current Assets -86.93 Cr105.77 Cr120.03 Cr142.01 Cr
Cash & Equivalents -2.37 Cr30.53 L1.07 Cr1.20 Cr
Inventory -29.93 Cr37.58 Cr39.33 Cr45.92 Cr
Receivables -39.04 Cr41.39 Cr43.24 Cr67.32 Cr
Total Liabilities -47.33 Cr56.81 Cr82.69 Cr98.88 Cr
Current Liabilities -45.40 Cr53.97 Cr73.13 Cr91.27 Cr
Long Term Debt -1.46 Cr2.37 Cr9.44 Cr6.97 Cr
Total Debt -25.52 Cr34.55 Cr60.29 Cr74.48 Cr
Total Equity -70.40 Cr78.51 Cr89.71 Cr104.19 Cr
Shares Outstanding 1.81 Cr1.81 Cr1.81 Cr1.81 Cr-

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow --7.54 Cr1.36 Cr23.68 Cr19.44 Cr
Investing Cash Flow --25.10 Cr-2.73 Cr-45.49 Cr-20.42 Cr
Financing Cash Flow -31.74 Cr40.89 L22.33 Cr1.11 Cr
Capital Expenditure --1.69 Cr-2.56 Cr-3.44 Cr-5.79 Cr
Free Cash Flow --9.23 Cr1.36 Cr20.24 Cr13.65 Cr
Net Change in Cash --89.69 L-96.10 L52.44 L13.10 L

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -25.1%34.6%48.9%49.6%
Operating Margin % -9.9%12.2%12.6%12.7%
Net Margin % -6.1%7.4%7.1%5.0%
ROE % -9.1%11.5%7.0%3.9%
ROCE % -14.3%18.3%9.5%8.5%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for QMSMEDI

Google News hu, 30 Apr 2026

Here's Why QMS Medical Allied Services (NSE:QMSMEDI) Has Caught The Eye Of Investors - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxQUXBnc1V3UmpIQlJiNTVHSVFXTWpvU2pCUjFqZVZHMGRJWXhlaGs5WUJpYjhaWGpYTGpMN0h0NDZoSXRoVDJWTEJVTm0yTGV3N09VNWxTcW44MlBoNFZidG91TW9GQVBVV0p3M25lRS1nMzVVRnB2QUVpOWQ0UEdaZWNoMkNyWmJrTzJ5bU…

Google News Sun, 14 Sep 2025

QMS Medical Allied Services Ltd - Equitypandit

<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTFA2V1ZMMHdhNnVKRnNWLVhUZGFwZ21KN3VYM2xpSDBlNEozNEdnYkhqQmRDYllLWWh3N01tZUliR1lDOUJPdHhMemFtZ0xub1N1YUFfaENjSzF6SENnZm9zU3RR?oc=5" target="_blank">QMS Medical Allied Services Ltd</a>…

Google News Wed, 20 Mar 2024

QMS MEDICAL ALLIED S LTD Share Price Today - Live QMSMEDI Stock Price for NSE/BSE - Upstox

<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE1xUXdYREp5dDAydUtDLUNyU09hY3ZZQ3Qza0VGNzNXX2IyZW8xVUd5QXhBVFlON0pqc3drclFOUHI0NEhoamxZY2dZbk16STRxNlBMMG92Z0NSd3JKb2o4NkgtWTNjZjFZd2ZZMzdsQTY?oc=5" target="_blank">QMS MEDICAL ALLI…

QMSMEDI — Frequently Asked Questions

What is the current share price of QMSMEDI.NS,0P0001PRY4,16000 (QMSMEDI)?

As of 2026-06-19 03:41 IST, QMSMEDI.NS,0P0001PRY4,16000 (QMSMEDI) trades at ₹109.40 on NSE. Its 52-week range is ₹72.00 to ₹109.40.

What is the market capitalisation of QMSMEDI?

QMSMEDI.NS,0P0001PRY4,16000 (QMSMEDI) has a market capitalisation of ₹183.71 Cr on NSE.

What is the P/E ratio of QMSMEDI?

QMSMEDI trades at a trailing price-to-earnings (P/E) ratio of 48.22. The industry average P/E is 36.33. Its price-to-book (P/B) ratio is 3.43.

Does QMSMEDI pay a dividend?

QMSMEDI.NS,0P0001PRY4,16000 (QMSMEDI) currently offers a dividend yield of 0.52%.

What is the return on equity (ROE) of QMSMEDI?

QMSMEDI has a return on equity (ROE) of 10.78%. Its return on capital employed (ROCE) is 8.96%.

Is QMSMEDI a good stock to buy?

This page provides a data-driven analysis of QMSMEDI.NS,0P0001PRY4,16000 (QMSMEDI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space